Electromed, Inc. ELMD
Set alert
As of Nov 2, 3:16 PM ET
- YTD
- -7.49%
- 1 year
- +11.97%
- Open
- 27.34
- Prev close
- 27.04
- Mkt cap
- 222.67M
- Vol
- 36.92K
- Avg vol
- 84.19K
- EPS
- 1.30
- P/E
- 20.67
- Div yield
- 0.00%
More statistics
- Low
- 26.45
- High
- 27.56
- Forward P/E
- 46.97
- Beta
- 0.26
- Short ratio
- 2.66
- Inst. own
- 36.07%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 11, 2025
- 50-d avg
- 26.42
- 200-d avg
- 18.87
- 1y target
- 33.00
6M chart
Signals (23)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Aug 26, 2026 | 2 months ago |
| RSI: Oversold | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 15, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| RSI: Overbought | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| RSI: Overbought | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 11, 2026 | 5 months ago |
| SMA: Bullish | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | May 6, 2026 | 6 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
Key statistics
- Market cap
- 242.32M
- Enterprise value
- 224.08M
- Trailing P/E
- 39.79
- Forward P/E
- 46.97
- PEG ratio
- 0.00
- Price / sales
- 4.43
- Price / book
- 5.56
- EPS (TTM)
- 0.72
- Beta
- 0.26
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 9.41%
- Revenue (TTM)
- 54.72M
- Revenue growth
- 9.00%
- Free cash flow
- 8.20M
- Total cash
- 16.08M
- Total debt
- 87.00K
- Return on equity
- 12.53%
- Shares outstanding
- 8.46M
- Short % of float
- 1.94%
- 50-day average
- 26.42
- 200-day average
- 18.87
Analyst view
Consensus: none
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 11, 2025
Expected Feb 11, 2025. Consensus EPS estimate 0.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2025 | Dec 1, 2024 | 0.00 | — | — | — |
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | 0.16 | — | — |
| Aug 27, 2024 | Jun 1, 2024 | 0.00 | 0.20 | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.00 | 0.17 | — | — |
| Feb 13, 2024 | Dec 1, 2023 | 0.00 | 0.19 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | 0.02 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 11, 2023 | EF Hutton | reit | Buy | Buy |
| Feb 16, 2023 | EF Hutton | main | — | Buy |
| Feb 15, 2023 | Lake Street | main | — | Buy |
| Sep 6, 2022 | EF Hutton | init | — | Buy |
| Aug 5, 2022 | Lake Street | init | — | Buy |
| Nov 24, 2020 | Northland Capital Markets | init | — | Outperform |
About Electromed, Inc.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- smartvest.com
News
- Electromed, Inc. to Report Q1 Fiscal 2027 Financial Results on November 10, 2026
- Cytosorbents (NASDAQ:CTSO) versus Electromed (NYSE:ELMD) Head to Head Comparison
- Squarepoint Ops LLC Purchases Shares of 19,498 Electromed, Inc. $ELMD
- Electromed, Inc. to Participate in the H.C. Wainwright 28th Annual Global Investment Conference and LD Micro 20th Annual Main Event
- Electromed: Contrarian 'Buy' With SmartVest
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- Lake Street Maintains Buy on Electromed, Raises Price Target to $47
- Electromed, Inc. (ELMD) Q4 2026 Earnings Call Transcript
- Electromed, Inc. (ELMD) Surpasses Q4 Earnings Estimates
- Electromed Q4 2026 Earnings Call: Complete Transcript
Your note
Sign in to keep a note on ELMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CUNNIFF JAMES L. | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 29, 2024 | 78,974 |
| ERICKSON STAN K | Director | Stock Award(Grant) | Nov 28, 2024 | 37,317 |
| FLUET GREGORY J | Director | Stock Award(Grant) | Nov 28, 2024 | 18,000 |
| GALATOWITSCH JOSEPH L | Director | Stock Award(Grant) | Nov 28, 2024 | 12,000 |
| NAGEL BRADLEY M. | Chief Financial Officer | Stock Award(Grant) | Sep 2, 2024 | 17,100 |
| SKARVAN KATHLEEN S | Director | Stock Award(Grant) | Nov 28, 2024 | 84,383 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.34% | 367,114 | 10.52M | Sep 29, 2024 |
| Punch & Associates Investment Management, Inc. | 4.26% | 360,244 | 10.32M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 3.29% | 278,462 | 7.98M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 2.53% | 214,103 | 6.13M | Sep 29, 2024 |
| Gamco Investors Inc | 1.60% | 135,000 | 3.87M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 1.46% | 123,404 | 3.54M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.00% | 253,800 | 7.27M | Sep 29, 2024 |
| EQ Advisors Trust-1290 VT Gamco Small Company Value Port | 1.60% | 135,000 | 3.87M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.16% | 98,146 | 2.81M | Sep 29, 2024 |
| DFA U.S. Small Cap Series | 0.70% | 59,305 | 1.70M | Jul 30, 2024 |
| DFA U.S. Targeted Value Portfolio | 0.61% | 51,264 | 1.47M | Jul 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.59% | 49,963 | 1.43M | Sep 29, 2024 |